GRI standards

GRI standards

Universal standards

Organization profile

Disclosure

External assurance

Report reference

SDG

102-1

Name of the organization

nxr_UCB_csr16_icons_circle-full.png

 

Scope of reporting

 

102-2

Activities, brands, products, and services

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders
Our business

102-3

Location of headquarters

nxr_UCB_csr16_icons_circle-full.png

 

We are UCB

 

102-4

Location of operations

nxr_UCB_csr16_icons_circle-full.png

β

We are UCB

 

102-5

Ownership and legal form

nxr_UCB_csr16_icons_circle-full.png

 

Corporate governance statement
Shareholders and shareholders structure

 

102-6

Markets served

nxr_UCB_csr16_icons_circle-full.png

β

We are UCB

 

102-7

Scale of the organization

 

Total number of employees

nxr_UCB_csr16_icons_circle-full.png

β

Our people

 

Total number of operations

nxr_UCB_csr16_icons_circle-full.png

β

We are UCB

 

Net sales (for private sector organizations) or net revenues (for public sector
organizations)

nxr_UCB_csr16_icons_circle-full.png

β

Letter to our stakeholders
Our performance
Our financials

 

Total capitalization (for private sector organizations) broken down in terms of debt and equity

nxr_UCB_csr16_icons_circle-full.png

β

Our financials

 

Quantity of products or services provided

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders
Our Patient Value Strategy
We are UCB

102-8

Information on employees and other workers

 

Total number of employees by employment contract (permanent and temporary), by gender

nxr_UCB_csr16_icons_circle-full.png

β

People data

 

Total number of employees by employment contract (permanent and temporary), by region

nxr_UCB_csr16_icons_circle-full.png

β

People data

 

Total number of employees by employment type (full-time and part-time), by gender

nxr_UCB_csr16_icons_circle-full.png

β

People data

 

Whether a significant portion of the organization’s activities are performed by workers who are not employees. If applicable, a description of the nature and scale of work performed by workers who are not employees

nxr_UCB_csr16_icons_circle-full.png

β

People data

 

Any significant variations in the numbers reported in Disclosures 102-8-a, 102-8-b, and 102-8-c (such as seasonal variations in the tourism or agricultural industries)

nxr_UCB_csr16_icons_circle-full.png

 

No significant variations

 

An explanation of how the data have been compiled, including any assumptions made

nxr_UCB_csr16_icons_circle-full.png

β

Our people – committed to bringing value to patients

102-9

Supply chain

nxr_UCB_csr16_icons_circle-full.png

 

Manufacturing & Supply: connecting development sciences with patient experience




102-10

Significant changes to the organization and its supply chain

nxr_UCB_csr16_icons_circle-full.png

 

Manufacturing & Supply: connecting development sciences with patient experience

 

102-11

Precautionary Principle or approach

nxr_UCB_csr16_icons_circle-full.png

 

Risk management

 

102-12

External initiatives

nxr_UCB_csr16_icons_circle-full.png

 

Engaging with industry associations
Partnering to deliver our ambition for patients
Engaging with local communities


102-13

Membership of associations

nxr_UCB_csr16_icons_circle-full.png

 

Engaging with industry associations


 

 

 

 

 

 

Strategy

Disclosure

External assurance

Report reference

SDG

102-14

Statement from senior decision-maker

nxr_UCB_csr16_icons_circle-full.png

 

Letter to our stakeholders

 

102-15

Key impacts, risks, and opportunities

nxr_UCB_csr16_icons_circle-full.png

 

Risk management

 

 

 

 

 

 

 

Ethics and integrity

Disclosure

External assurance

Report reference

SDG

102-16

Values, principles, standards, and norms of behavior

nxr_UCB_csr16_icons_circle-full.png

β

Our ambition for patients
Business conduct

102-17

Mechanisms for advice and concerns about ethics

nxr_UCB_csr16_icons_circle-full.png

 

Promoting and embracing ethical behaviors across the organizations

 

 

 

 

 

 

Governance

Disclosure

External assurance

Report reference

SDG

102-18

Governance structure

nxr_UCB_csr16_icons_circle-full.png

β

Our governance

 

102-20

Executive-level responsibility for economic, environmental, and social topics

nxr_UCB_csr16_icons_circle-full.png

 

Strengthened organizational model
Board of Directors and Board committees

102-21

Consulting stakeholders on economic, environmental, and social topics

nxr_UCB_csr16_icons_circle-full.png

 

Our 2019 materiality assessment

102-22

Composition of the highest governance body and its committees

nxr_UCB_csr16_icons_circle-full.png

 

Board of Directors and Board committees


102-23

Chair of the highest governance body

nxr_UCB_csr16_icons_circle-full.png

 

Board of Directors and Board committees

102-24

Nominating and selecting the highest governance body

nxr_UCB_csr16_icons_circle-half.png

 

Board of Directors and Board committees

102-26

Role of highest governance body in setting purpose, values, and strategy

nxr_UCB_csr16_icons_circle-half.png

 

Executive Committee

 

102-30

Effectiveness of risk management processes

nxr_UCB_csr16_icons_circle-full.png

 

Risk management

 

102-32

Highest governance body’s role in sustainability reporting

nxr_UCB_csr16_icons_circle-full.png

 

Strengthened organizational model

 

102-40

List of stakeholder groups

nxr_UCB_csr16_icons_circle-full.png

 

Our 2019 materiality assessment
Engaging with industry associations

 

102-41

Collective bargaining agreements

nxr_UCB_csr16_icons_circle-half.png

 

Collective bargaining agreements are country-specific

 

 

 

 

 

 

 

Stakeholder engagement

Disclosure

External assurance

Report reference

SDG

102-42

Identifying and selecting stakeholders

nxr_UCB_csr16_icons_circle-full.png

 

Our 2019 materiality assessment

 

102-43

Approach to stakeholder engagement

nxr_UCB_csr16_icons_circle-full.png

 

Our 2019 materiality assessment

 

102-44

Key topics and concerns raised

nxr_UCB_csr16_icons_circle-full.png

 

Our 2019 materiality assessment

 

 

 

 

 

 

 

Reporting principles

Disclosure

External assurance

Report reference

SDG

102-45

Entities included in the consolidated financial statements

nxr_UCB_csr16_icons_circle-full.png

 

Our financials

 

102-46

Defining report content and topic Boundaries

nxr_UCB_csr16_icons_circle-full.png

 

About this report
Our 2019 materiality assessment

 

102-47

List of material topics

nxr_UCB_csr16_icons_circle-full.png

 

Our commitments to stakeholders
Our 2019 materiality assessment

 

102-48

Restatements of information

nxr_UCB_csr16_icons_circle-full.png

 

Our progress against Green Goals

 

102-49

Changes in reporting

nxr_UCB_csr16_icons_circle-full.png

 

Engaging and partnering with our stakeholders
Data & reporting

 

102-50

Reporting period

nxr_UCB_csr16_icons_circle-full.png

β

Our performance

 

102-51

Date of most recent report

nxr_UCB_csr16_icons_circle-full.png

β

Our performance

 

102-52

Reporting cycle

nxr_UCB_csr16_icons_circle-full.png

β

Our performance

 

102-53

Contact point for questions regarding the report

nxr_UCB_csr16_icons_circle-full.png

β

Contact details

 

102-54

Claims of reporting in accordance with the GRI Standards

nxr_UCB_csr16_icons_circle-full.png

β

About this report
Our 2019 materiality assessment

 

102-55

GRI content index

nxr_UCB_csr16_icons_circle-full.png

β

GRI standards

 

102-56

External assurance

nxr_UCB_csr16_icons_circle-full.png

β

Assurance report

 

 

 

 

 

 

 

Topic specific standards

Economic

Economic performance

Disclosure

External assurance

Report reference

SDG

GRI 201: Economic performance 2019

 

 

 

 

201-1

Direct economic value generated and distributed

nxr_UCB_csr16_icons_circle-full.png

β

Our financials

201-3

Defined benefit plan obligations and other retirement plans

nxr_UCB_csr16_icons_circle-full.png

β

Our financials

 

 

 

 

 

 

 

Market presence

Disclosure

External assurance

Report reference

SDG

GRI 202: Market presence 2019

 

 

 

 

202-2

Proportion of senior management hired from the local community

nxr_UCB_csr16_icons_circle-full.png

 

Fostering an inclusive and diverse organization


 

 

 

 

 

 

Anti-corruption

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

 

GRI 205: Anti-corruption 2019

 

 

 

 

205-1

Operations assessed for risks related to corruption

nxr_UCB_csr16_icons_circle-half.png

 

Anti-Bribery and Anti-Corruption

205-2

Communication and training about anti-corruption policies and procedures

nxr_UCB_csr16_icons_circle-half.png

 

Business conduct
Anti-Bribery and Anti-Corruption
People data

 

Total number and percentage of governance body members that the organization’s anti-corruption policies and procedures have been communicated to, broken down by region

 

 

No disclosure

 

Total number and percentage of employees that the organization’s anti-corruption policies and procedures have been communicated to, broken down by employee category and region

 

 

No disclosure

 

Total number and percentage of business partners that the organization’s anti-corruption policies and procedures have been communicated to, broken down by type of business partner and region. Describe if the organization’s anti-corruption policies and procedures have been communicated to any other persons or organizations

 

 

No disclosure

 

Total number and percentage of governance body members that have received training on anti-corruption, broken down by region

 

 

No disclosure

 

Total number and percentage of employees that have received training on anti-corruption, broken down by employee category and region

nxr_UCB_csr16_icons_circle-half.png

β

Anti-Bribery and Anti-Corruption
People data

205-3

Confirmed incidents of corruption and actions taken

nxr_UCB_csr16_icons_circle-half.png

 

Anti-Bribery and Anti-Corruption

 

 

 

 

 

 

Environmental

Energy

Disclosure

External assurance

Report reference

SDG

GRI 302: Energy 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

302-1

Energy consumption within the organization

nxr_UCB_csr16_icons_circle-full.png

β

Minimizing our environmental footprint





302-4

Reduction of energy consumption

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint





 

 

 

 

 

 

Water

Disclosure

External assurance

Report reference

SDG

GRI 303: Water and effluents 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

303-1

Water withdrawal by source

nxr_UCB_csr16_icons_circle-full.png

β

Reducing water withdrawal by 20% by 2030
Environmental data



 

 

 

 

 

 

Emissions

Disclosure

External assurance

Report reference

SDG

GRI 305: Emissions 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

305-1

Direct (Scope 1) GHG emissions

nxr_UCB_csr16_icons_circle-full.png

β

Minimizing our environmental footprint




305-2

Energy indirect (Scope 2) GHG emissions

nxr_UCB_csr16_icons_circle-full.png

β

Minimizing our environmental footprint




305-3

Other indirect (Scope 3) GHG emissions

nxr_UCB_csr16_icons_circle-half.png

 

Minimizing our environmental footprint




 

 

 

 

 

 

Effluents and waste

Disclosure

External assurance

Report reference

SDG

GRI 306: Effluents and waste 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Minimizing our environmental footprint

 

306-2

Waste by type and disposal method

nxr_UCB_csr16_icons_circle-full.png

β

Minimizing our environmental footprint



306-3

Significant spills

nxr_UCB_csr16_icons_circle-full.png

β

Minimizing our environmental footprint





306-4

Transport of hazardous waste

nxr_UCB_csr16_icons_circle-full.png

β

Minimizing our environmental footprint


 

 

 

 

 

 

Social

Employment

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

 

GRI 401: Employment 2019

 

 

 

 

401-1

New employee hires and employee turnover

nxr_UCB_csr16_icons_circle-full.png

β

Our talent acquisition process
People data


 

 

 

 

 

 

Occupational health and safety

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

 

GRI 403: Occupational health and safety 2019

 

 

 

 

403-2

Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities

nxr_UCB_csr16_icons_circle-half.png

 

Offering support for health and well-being, promoting safe behaviors


403-3

Workers with high incidence or high risk of diseases related to their occupation

nxr_UCB_csr16_icons_circle-half.png

 

Offering support for health and well-being, promoting safe behaviors


 

 

 

 

 

 

Training and education

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

 

GRI 404: Training and education 2019

 

 

 

 

404-1

Average hours of training per year per employee

nxr_UCB_csr16_icons_circle-full.png

β

Our learning and personalized development process



404-3

Percentage of employees receiving regular performance and career development reviews

nxr_UCB_csr16_icons_circle-half.png

 

Our learning and personalized development process


 

 

 

 

 

 

Diversity and equal opportunity

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘People Management and People Development’ are being managed by the Talent and Company Reputation Patient Value Function.

 

GRI 405: Diversity and equal opportunity 2019

 

 

 

 

405-1

Diversity of governance bodies and employees

nxr_UCB_csr16_icons_circle-full.png

β

Fostering an inclusive and diverse organization
Our governance
People data



 

 

 

 

 

 

Non-discrimination

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

 

GRI 406: Non-discrimination 2019

 

 

 

 

406-1

Incidents of discrimination and corrective actions taken

nxr_UCB_csr16_icons_circle-full.png

 

Diversity and inclusion




 

 

 

 

 

 

Child labor

Disclosure

External assurance

Report reference

SDG

GRI 408: Child labor 2019

 

 

 

 

408-1

Operations and suppliers at significant risk for incidents of child labor

nxr_UCB_csr16_icons_circle-half.png

 

Human rights

 

 

 

 

 

 

Human rights assessment

Disclosure

External assurance

Report reference

SDG

GRI 412: Human rights assessment 2019

 

 

 

 

412-2

Employee training on human rights policies or procedures

nxr_UCB_csr16_icons_circle-half.png

 

Business conduct
People data

 

 

Total number of hours in the reporting period devoted to training on human rights policies or procedures concerning aspects of human rights that are relevant to operations

 

 

No disclosure

 

Percentage of employees trained during the reporting period in human rights policies or procedures concerning aspects of human rights that are relevant to operations

nxr_UCB_csr16_icons_circle-full.png

β

Responsible Business Conduct
People data

 

 

 

 

 

 

Local communities

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspects ‘Access to Health and Medicines, Pricing and Disease Awareness and Education’ are being managed by the Marketing and Patient Access Patient Value Practice and Talent and Company Reputation Patient Value Function, supported by other departments.

 

GRI 413: Local communities 2019

 

 

 

 

413-1

Operations with local community engagement, impact assessments, and development programs

nxr_UCB_csr16_icons_circle-full.png

 

Engaging with local communities






 

 

 

 

 

 

Customer health and safety

Disclosure

External assurance

Report reference

SDG

GRI 416: Customer health and safety 2019

 

 

 

 

416-1

Assessment of the health and safety impacts of product and service categories

nxr_UCB_csr16_icons_circle-full.png

 

Patient and drug safety

416-2

Incidents of non-compliance concerning the health and safety impacts of products and services

nxr_UCB_csr16_icons_circle-full.png

 

Product responsibility


 

 

 

 

 

 

Marketing and labeling

Disclosure

External assurance

Report reference

SDG

GRI 417: Marketing and labeling 2019

 

 

 

 

417-1

Requirements for product and service information and labeling

nxr_UCB_csr16_icons_circle-half.png

 

Patient and drug safety

 

 

 

 

 

 

Customer privacy

Disclosure

External assurance

Report reference

SDG

The progress of the actions and mitigation of potential risks relative to the very relevant material aspect ‘Personal and Confidential Information, Business Ethics and Anti-Bribery and Anti-Corruption’ are being managed by the Ethics and Compliance department, within the Legal Patient Value Function.

 

GRI 418: Customer privacy 2019

 

 

 

 

418-1

Substantiated complaints concerning breaches of customer privacy and losses of customer data

nxr_UCB_csr16_icons_circle-full.png

 

Risk management

 

 

 

 

 

 

 

Employee engagement

Disclosure

External assurance

Report reference

SDG

GRI 501: Employee engagement 2019

 

 

 

 

501-1

Percentage of colleagues engaging in Employee survey

nxr_UCB_csr16_icons_circle-full.png

 

Employee Insights

 

501-2

Percentage of colleagues completing the mandatory training programs

nxr_UCB_csr16_icons_circle-full.png

 

Responsible Business Conduct
Anti-Bribery and Anti-Corruption


 

 

 

 

 

 

Innovation

Disclosure

External assurance

Report reference

SDG

GRI 601: Innovation 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Research and Development

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Research and Development

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Research and Development

 

601-1

Percentage of the revenue invested in R&D

nxr_UCB_csr16_icons_circle-full.png

 

Our performance

601-2

Number of assets in Pipeline (FIH, Label)

nxr_UCB_csr16_icons_circle-full.png

 

Our performance
Research and Development


601-3

Number of first approvals

nxr_UCB_csr16_icons_circle-full.png

 

Our performance


 

 

 

 

 

 

Access to Medicines

Disclosure

External assurance

Report reference

SDG

GRI 701: Access to Medicines 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Patient access

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Patient access

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Patient access

 

701-1

Access to Medicines

nxr_UCB_csr16_icons_circle-full.png

 

Patient access

 

 

 

 

 

 

Health and well-being

Disclosure

External assurance

Report reference

SDG

GRI 801: Health and well-being 2019

 

 

 

 

103-1

Explanation of the material topic and its Boundary

nxr_UCB_csr16_icons_circle-full.png

 

Offering support for health and well-being

 

103-2

The management approach and its components

nxr_UCB_csr16_icons_circle-full.png

 

Offering support for health and well-being

 

103-3

Evaluation of the management approach

nxr_UCB_csr16_icons_circle-full.png

 

Offering support for health and well-being

 

801-1

Health and well-being

nxr_UCB_csr16_icons_circle-full.png

 

Offering support for health and well-being